We recently published an article titled Jim Cramer’s Lightning Rounds: 9 Stocks in Focus. In this article, we are going to ...
Nisa Investment Advisors LLC grew its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 23.1% ...
The firm will share new overall survival data from the INAVO120 trial with regulators to support the breast cancer drug's approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback